Three baseball-related SPACs have attractive potential, but when will they reward investors?
It's the type of transition the Biden team probably would put its antitrust lawyers on to squelch, again leaving Intel with no quick fix.
Here's my answer to a tough question.
Ardelyx Inc. and Rigel Pharmaceuticals look good as stand-alone companies but also could attract suitors.
Plus, the chart of Tesla indicates it's time to be wary if you're in the stock at present.
However, shares of the maker of agricultural and construction equipment still could see a period of sideways price action for a while.
Shares of the SPAC that soon will be the vehicle to take e-commerce grocery platform Boxed public have firmed of late.
The insurer's recent sale of a chunk of its business has led the company to share in the proceeds with its shareholders.
I still believe TR would command a solid premium in an acquisition, but I'm not holding my breath.
The cannabis biotech company explains why the acquisition of MagicMed makes sense, additional capital raises and the Psybrary.
There's a merger involving one company, a collaborative agreement for another and hints of a positive regulatory development for a third.
There's one name I would consider adding back to full on any coming weakness.
The largest-ever merger in Indonesian history will combine the country's two best-known online brands.
Plus, Elon Musk stirs the pot again in the cryptocurrency universe.
Crown Resorts has competing bids from Blackstone, Oaktree Capital and Australia's second-largest casino company, Star.
HIG rejected multiple offers from rival Chubb.
SWKS is probably going higher.
JHG offers significant upside potential, plus a 4.4% yield.
We have to care about this bidding war because there's a lot more woe-is-me going on about stocks right now than there should be.
Bids from Western venture capital investors for age-old Japanese names are only likely to increase.
The deal for Grab would involve U.S. tech venture capital firm Altimeter Capital Management.
Who do you think probably better understands this business... one of the very best analysts on the entire street or the FTC?
Let's look at the charts of this SPAC behind the Paysafe deal.
You can still find good plays in special purpose acquisitions, if you look in the right places and know what you're doing.
We've just been handed an asymmetric risk opportunity.
We're now at the point of saturation, where the bad special purpose acquisition companies are driving out the good ones. So, don't blame the messenger.
Let this play out, and then revisit it if it's a sector that interests you because there could be something there worth considering.
Despite a damning report that Crown shouldn't get a license for a new casino in Sydney, BX wants to buy them for A$8 billion.
The Fed has probably refined what message that it wants to put forth and has sent the minions out to speak its current version of "truth".